Overall, our findings align with previous reports showing limited IL-17A involvement in neurodegenerative conditions, contrasting with its well-established role in autoimmune diseases where sustained Th17 activation is a hallmark [41]. This evidence concerns the gene IL17A and autoimmune disease.